Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study.

about

Emerging drugs for the treatment of angina pectoris.

P2860

Q38967994-B91DA631-2913-482E-A081-4F0BEA9193B9

P2860

Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study.

Item

http://www.wikidata.org/entity/Q36844494

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study.

@en

type

Item

label

Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study.

@en

prefLabel

Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study.

@en

P1476

Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study

@en

P2093

Eun-Seok Shin

http://www.w3.org/2001/XMLSchema#string

Jeong-Su Kim

http://www.w3.org/2001/XMLSchema#string

Jun Kim

http://www.w3.org/2001/XMLSchema#string

June-Hong Kim

http://www.w3.org/2001/XMLSchema#string

Kook-Jin Chun

http://www.w3.org/2001/XMLSchema#string

Sang-Yong Yoo

http://www.w3.org/2001/XMLSchema#string

Sung-Gook Song

http://www.w3.org/2001/XMLSchema#string

Yong-Hyun Park

http://www.w3.org/2001/XMLSchema#string

P2860

Cilostazol in secondary prevention of stroke: impact of the Cilostazol Stroke Prevention Study

Effect of cilostazol on vasomotor reactivity in patients with vasospastic angina pectoris

Assessment and treatment of endothelial dysfunction in humans.

Cilostazol as a unique antithrombotic agent.

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

Antiplatelet and anticoagulant agents: key differences in mechanisms of action, clinical application, and therapeutic benefit in patients with non-ST-segment-elevation acute coronary syndromes.

Effects of cilostazol in the heart.

Endothelium-dependent relaxation by cilostazol, a phosphodiesteras III inhibitor, on rat thoracic aorta.

cAMP signal transduction cascade, a novel pathway for the regulation of endothelial nitric oxide production in coronary blood vessels.

Effect of cilostazol on platelet aggregation and experimental thrombosis.

P304

179-185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1755-5922.2012.00312.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jae-Hwan Lee

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230809427

http://www.w3.org/2001/XMLSchema#string

P698

22953758

http://www.w3.org/2001/XMLSchema#string

P932

3654168

http://www.w3.org/2001/XMLSchema#string

Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study.

about

P2860

P2860

Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932